Dual Effect of Ziconotide in Primary Erythromelalgia.

Erythromelalgia (EM) is a rare disabling clinical syndrome more commonly known to affect the lower extremities. There is no single effective treatment for this disease that often requires a multidisciplinary approach. Herein, we report the case of a 31-year-old woman affected by primary erythromelalgia who was successfully treated with intrathecal Ziconotide. We also observed an unexpected result following therapy with Ziconotide. The legs and feet of the patient that at the time of admission were swollen and tumefied dramatically improved after one week of the drug administration.

[Substernal goiter: pre-, intra- and postoperative problems]. / Le problematiche pre-, intra- e postoperatorie del gozzo immerso.

The Authors report their experience with problems in treating substernal goiter. They then explain at length the complex haemodynamic or respiratory situations encountered and the therapeutic management of the condition. Also discussed are technical surgical problems, and the prevention and therapy of possible complications. They conclude by stating that thanks to all the technical means currently available complete patient control can be achieved before, during and after the operation, thus significantly contributing to the successful outcome of surgical treatment.